Cargando…

Prevention And Treatment of Hypertension With Algorithm-based therapy (PATHWAY) number 2: protocol for a randomised crossover trial to determine optimal treatment for drug-resistant hypertension

INTRODUCTION: Resistant hypertension is inadequately controlled blood pressure (BP) despite treatment with at least three BP-lowering drugs. A popular hypothesis is that resistant hypertension is due to excessive Na(+)-retention, and that ‘further diuretic therapy’ will be superior to alternative ad...

Descripción completa

Detalles Bibliográficos
Autores principales:	Williams, Bryan, MacDonald, Thomas M, Caulfield, Mark, Cruickshank, J Kennedy, McInnes, Gordon, Sever, Peter, Webb, David J, Salsbury, Jackie, Morant, Steve, Ford, Ian, Brown, Morris J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2015
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4538257/ https://www.ncbi.nlm.nih.gov/pubmed/26253568 http://dx.doi.org/10.1136/bmjopen-2015-008951

Ejemplares similares

Monotherapy versus dual therapy for the initial treatment of hypertension (PATHWAY-1): a randomised double-blind controlled trial
por: MacDonald, Thomas M, et al.
Publicado: (2015)

Comparison of single and combination diuretics on glucose tolerance (PATHWAY-3): protocol for a randomised double-blind trial in patients with essential hypertension
por: Brown, Morris J, et al.
Publicado: (2015)

Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial
por: Williams, Bryan, et al.
Publicado: (2015)

Combination Therapy Is Superior to Sequential Monotherapy for the Initial Treatment of Hypertension: A Double‐Blind Randomized Controlled Trial
por: MacDonald, Thomas M., et al.
Publicado: (2017)

Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies
por: Williams, Bryan, et al.
Publicado: (2018)

Effect of amiloride, or amiloride plus hydrochlorothiazide, versus hydrochlorothiazide on glucose tolerance and blood pressure (PATHWAY-3): a parallel-group, double-blind randomised phase 4 trial
por: Brown, Morris J, et al.
Publicado: (2016)

Methods of a large prospective, randomised, open-label, blinded end-point study comparing morning versus evening dosing in hypertensive patients: the Treatment In Morning versus Evening (TIME) study
por: Rorie, David A, et al.
Publicado: (2016)

Timeline of History of Hypertension Treatment
por: Saklayen, Mohammad G., et al.
Publicado: (2016)

Advances in pathogenesis and treatment of essential hypertension
por: Ma, Jun, et al.
Publicado: (2022)

Risk Factors for the Comorbidity of Hypertension and Renal Cell Carcinoma in the Cardio-Oncologic Era and Treatment for Tumor-Induced Hypertension
por: Ba, Zhengqing, et al.
Publicado: (2022)

Postpartum blood pressure self-management following hypertensive pregnancy: protocol of the Physician Optimised Post-partum Hypertension Treatment (POP-HT) trial
por: Kitt, Jamie, et al.
Publicado: (2022)

Cardiovascular Hypertension-Mediated Organ Damage in Hypertensive Urgencies and Hypertensive Outpatients
por: Vallelonga, Fabrizio, et al.
Publicado: (2022)

COVID and the Renin-Angiotensin System: Are Hypertension or Its Treatments Deleterious?
por: Zores, Florian, et al.
Publicado: (2020)

Clinical Relevance of Right Atrial Functional Response to Treatment in Pulmonary Arterial Hypertension
por: Richter, Manuel J., et al.
Publicado: (2021)

Association of Uric Acid With Blood Pressure in Hypertension Between Treatment Group and Non-treatment Group
por: Ding, Ning, et al.
Publicado: (2022)

Baduanjin exercise in the treatment of hypertension: A systematic review and meta-analysis
por: Ma, Zhen, et al.
Publicado: (2022)

Identification of intrinsic genes across general hypertension, hypertension with left ventricular remodeling, and uncontrolled hypertension
por: Yu, Chun-yang, et al.
Publicado: (2022)

SAT-546 Endoscopic Ultrasound-Guided Radiofrequency Ablation (EUS-RFA) as an Alternative to Adrenalectomy for the Treatment of Aldosterone-Producing Adenomas (APAs)
por: Wu, Xilin, et al.
Publicado: (2020)

Barriers to Treatment and Control of Hypertension among Hypertensive Participants: A Community-Based Cross-sectional Mixed Method Study in Municipalities of Kathmandu, Nepal
por: Devkota, Surya, et al.
Publicado: (2016)

OR34-07 Prospective Multicentre Study Comparing (11)C-metomidate PET CT with Adrenal Vein Sampling (AVS) in the Detection of Unilateral Aldosterone-Producing Adenomas (APAs)
por: Wu, Xilin, et al.
Publicado: (2020)

Bacterial-Induced Blood Pressure Reduction: Mechanisms for the Treatment of Hypertension via the Gut
por: Cookson, Tyler Alexander
Publicado: (2021)

Barriers, Enablers and Strategies for the Treatment and Control of Hypertension in Nepal: A Systematic Review
por: Dhungana, Raja Ram, et al.
Publicado: (2021)

Editorial: Hypertensive disorders of pregnancy and the cardiovascular system: Causes, consequences, prevention and treatment
por: Dierickx, Inge, et al.
Publicado: (2023)

Hypertension in Women
por: Tasić, Tatjana, et al.
Publicado: (2022)

Awareness of hypertension and factors associated with uncontrolled hypertension in Sudanese adults
por: Babiker, Fawzi A, et al.
Publicado: (2013)

First Line CombinAtion Therapy in the Treatment of Stage II and III Hypertension (FLASH)
por: Spirk, David, et al.
Publicado: (2020)

Prediction of Masked Hypertension and Masked Uncontrolled Hypertension Using Machine Learning
por: Hung, Ming-Hui, et al.
Publicado: (2021)

The Association Between Hypertensive Disorders in Pregnancy and the Risk of Developing Chronic Hypertension
por: Xu, Jiahao, et al.
Publicado: (2022)

FRI156 Novel Radiolabeled Ligand, Para-chloro-2-[(18)F]fluoroethyletomidate (CETO) Is Equivalent To [11C]metomidate-PET (MTO) For The Lateralisation Of Primary Aldosteronism (PA)
por: Goodchild, Emily, et al.
Publicado: (2023)

Development of the roadmap for reducing cardiovascular morbidity and mortality through the detection, treatment and control of hypertension in Africa: report of a working group of the PAS CAR Hypertension Task Force
por: Dzudie, Anastase, et al.
Publicado: (2016)

Evidence for a Prehypertensive Water Dysregulation Affecting the Development of Hypertension: Results of Very Early Treatment of Vasopressin V1 and V2 Antagonism in Spontaneously Hypertensive Rats
por: Verzicco, Ignazio, et al.
Publicado: (2022)

The Challenges of Arterial Hypertension
por: Rossi, Gian Paolo
Publicado: (2015)

Hypertension and the Risk of Dementia
por: Sierra, Cristina
Publicado: (2020)

Editorial: Hypertension in the Elderly
por: Coca, Antonio, et al.
Publicado: (2021)

Editorial: Women in hypertension
por: Dorobantu, Maria, et al.
Publicado: (2023)

Awareness of hypertension guidelines and the diagnosis and evaluation of hypertension by primary care physicians in Nigeria
por: Ale, OK, et al.
Publicado: (2017)

Effect of the number of unhealthy lifestyles in middle-aged and elderly people on hypertension and the first occurrence of ischemic stroke after the disease
por: Zhu, Xiaopeng, et al.
Publicado: (2023)

Prevalence, awareness, treatment and control of hypertension among adults 50 years and older in Dakar, Senegal
por: Macia, E, et al.
Publicado: (2012)

Balloon Pulmonary Angioplasty: A Treatment Option for Inoperable Patients with Chronic Thromboembolic Pulmonary Hypertension
por: Ogawa, Aiko, et al.
Publicado: (2015)

Hypertension treatment practices and its determinants among ambulatory patients: retrospective cohort study in Ethiopia
por: Berhe, Derbew Fikadu, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_s6llh7q1cqndefefg227ft1gjb